Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Operating Profit

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Operating Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Operating Profit (Excl OI) ₹2,351 Cr₹1,195 Cr₹1,635 Cr₹2,320 Cr₹2,084 Cr

What is the latest Operating Profit of GLENMARK PHARMACEUTICALS ?

The latest Operating Profit ratio of GLENMARK PHARMACEUTICALS is ₹2,351 Cr based on Mar2026 Consolidated results.
Year Operating Profit
Mar2026₹2,351 Cr
Mar2025₹1,195 Cr
Mar2024₹1,635 Cr
Mar2023₹2,320 Cr
Mar2022₹2,084 Cr

How is Operating Profit of GLENMARK PHARMACEUTICALS Trending?

Years Operating Profit % Change
Mar2026 ₹2,351 Cr
96.71
Mar2025 ₹1,195 Cr
-26.89
Mar2024 ₹1,635 Cr
-29.53
Mar2023 ₹2,320 Cr
11.32
Mar2022 ₹2,084 Cr -

Compare Operating Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹74,585.5 Cr 1.9% 17.8% 44.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,291.0 Cr -1.8% 7.6% 11.2% Stock Analytics
DIVIS LABORATORIES ₹305,014.0 Cr 3.7% 27.2% 71.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,333.0 Cr -2.3% 1.5% 23.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,017.0 Cr 0.6% 13.4% 15.7% Stock Analytics
CIPLA ₹112,539.0 Cr -1.3% 6.1% -6.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.9%

17.8%

44.9%

SENSEX

0.7%

11.7%

-2%


You may also like the below Video Courses